The French drugmaker Sanofi says it hopes to get regulatory approval for the coronavirus vaccine it's developing with Britain's GlaxoSmithKline by the first half of next year.
There are currently no vaccines against the virus, and while a number of companies and institutions are in the race to develop one there is no guarantee of success.
Sanofi currently has two vaccine projects. Clinical trials of the GSK-linked project are due to start in September.
No comments:
Post a Comment